41 min listen
6. Computational Biology: Nan Li - Managing Director @ Obvious Ventures
FromBIOS
ratings:
Length:
52 minutes
Released:
Aug 29, 2020
Format:
Podcast episode
Description
Nan Li is a Managing Director @ Obvious Ventures, where he invests in companies solving the world’s biggest problems in sustainable systems, healthy living, and people power. At Obvious, his investments have included LabGenius, Recursion Pharmaceuticals, Darwin AI, Octave Health, Zymergen, and Planet. Prior to joining Obvious, Nan has had a mix of technology, investing, and entrepreneurship experiences including early stage tech investments at Innovation Endeavors, Product, Operations, and Finance at Gigwalk, VC and management consulting at Bain, and PM at Microsoft. Nan is also an adjunct lecturer at Stanford where he teaches a course on symbolic systems in VC and entrepreneurship.Topics:Computational biology investmentsUnderstanding the biology of investmentsApplying digital approaches to biologyAddressing computational drug design skepticsManaging fund cycle expectations in deep tech investingEast vs west coast investment mindsetsThank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license)
Released:
Aug 29, 2020
Format:
Podcast episode
Titles in the series (63)
4. Accelerating Life Sciences: Tony Kulesa - Co-Founder @ Petri by BIOS